Tags

Type your tag names separated by a space and hit enter

Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
Gastrointest Endosc 2015; 81(6):1408-16GE

Abstract

BACKGROUND

Risk factors for the development of post-ERCP pancreatitis (PEP) have not been identified in the pediatric population. It remains unclear what constitutes appropriate prophylaxis in this patient population.

OBJECTIVES

To assess the prevalence and severity of PEP in the pediatric population and identify factors associated with developing PEP and to evaluate the effect of prophylactic pancreatic duct stenting in high-risk patients.

DESIGN

Retrospective analysis of an ERCP database at a single large pediatric center.

SETTING

Academic center.

PATIENTS

A total of 432 ERCPs performed on 313 patients younger than 19 years of age from January 2004 to October 2013.

INTERVENTION

ERCP for any indication.

MAIN OUTCOME MEASUREMENTS

Rates and severity of PEP, preprocedural and procedural risk factors for the development of PEP, and the effect of pancreatic stents on preventing PEP in high-risk patients.

RESULTS

PEP occurred after 47 procedures (prevalence, 10.9%). Thirty-four cases were mild, 9 were moderate, and 4 were severe. There was no mortality. On multiple logistic analysis, pancreatic duct injection (P<.0001; odds ratio 30.8; 95% confidence interval [CI], 9.1-103.9) and pancreatic sphincterotomy (P<.01; OR 3.8; 95% CI, 1.6-9.8) were positively associated with PEP. A history of chronic pancreatitis was negatively associated with PEP (P<.05; OR 0.37; 95% CI, 0.15-0.93). On subset analysis, placing a prophylactic pancreatic stent was associated with significantly increased rates of PEP in patients with pancreatic duct injection compared with those who had no attempt at stent placement (P<.01). Two patients with severe pancreatitis had prophylactic pancreatic stents in place.

LIMITATIONS

Retrospective investigation.

CONCLUSIONS

In the pediatric population, pancreatic duct injection and pancreatic sphincterotomy are associated with significantly increased rates of PEP, whereas a history of chronic pancreatitis is negatively associated. Prophylactic pancreatic stenting is associated with higher rates of PEP in high-risk patients and does not eliminate severe PEP.

Authors+Show Affiliations

UT Southwestern Medical Center, Dallas, Texas, USA.Children's Medical Center, Dallas, Texas, USA.Children's Medical Center, Dallas, Texas, USA.UT Southwestern Medical Center, Dallas, Texas, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25686874

Citation

Troendle, David M., et al. "Factors Associated With post-ERCP Pancreatitis and the Effect Of pancreatic Duct Stenting in a Pediatric Population." Gastrointestinal Endoscopy, vol. 81, no. 6, 2015, pp. 1408-16.
Troendle DM, Abraham O, Huang R, et al. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. Gastrointest Endosc. 2015;81(6):1408-16.
Troendle, D. M., Abraham, O., Huang, R., & Barth, B. A. (2015). Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. Gastrointestinal Endoscopy, 81(6), pp. 1408-16. doi:10.1016/j.gie.2014.11.022.
Troendle DM, et al. Factors Associated With post-ERCP Pancreatitis and the Effect Of pancreatic Duct Stenting in a Pediatric Population. Gastrointest Endosc. 2015;81(6):1408-16. PubMed PMID: 25686874.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. AU - Troendle,David M, AU - Abraham,Omana, AU - Huang,Rong, AU - Barth,Bradley A, Y1 - 2015/02/14/ PY - 2014/05/20/received PY - 2014/11/10/accepted PY - 2015/2/18/entrez PY - 2015/2/18/pubmed PY - 2016/4/8/medline SP - 1408 EP - 16 JF - Gastrointestinal endoscopy JO - Gastrointest. Endosc. VL - 81 IS - 6 N2 - BACKGROUND: Risk factors for the development of post-ERCP pancreatitis (PEP) have not been identified in the pediatric population. It remains unclear what constitutes appropriate prophylaxis in this patient population. OBJECTIVES: To assess the prevalence and severity of PEP in the pediatric population and identify factors associated with developing PEP and to evaluate the effect of prophylactic pancreatic duct stenting in high-risk patients. DESIGN: Retrospective analysis of an ERCP database at a single large pediatric center. SETTING: Academic center. PATIENTS: A total of 432 ERCPs performed on 313 patients younger than 19 years of age from January 2004 to October 2013. INTERVENTION: ERCP for any indication. MAIN OUTCOME MEASUREMENTS: Rates and severity of PEP, preprocedural and procedural risk factors for the development of PEP, and the effect of pancreatic stents on preventing PEP in high-risk patients. RESULTS: PEP occurred after 47 procedures (prevalence, 10.9%). Thirty-four cases were mild, 9 were moderate, and 4 were severe. There was no mortality. On multiple logistic analysis, pancreatic duct injection (P<.0001; odds ratio 30.8; 95% confidence interval [CI], 9.1-103.9) and pancreatic sphincterotomy (P<.01; OR 3.8; 95% CI, 1.6-9.8) were positively associated with PEP. A history of chronic pancreatitis was negatively associated with PEP (P<.05; OR 0.37; 95% CI, 0.15-0.93). On subset analysis, placing a prophylactic pancreatic stent was associated with significantly increased rates of PEP in patients with pancreatic duct injection compared with those who had no attempt at stent placement (P<.01). Two patients with severe pancreatitis had prophylactic pancreatic stents in place. LIMITATIONS: Retrospective investigation. CONCLUSIONS: In the pediatric population, pancreatic duct injection and pancreatic sphincterotomy are associated with significantly increased rates of PEP, whereas a history of chronic pancreatitis is negatively associated. Prophylactic pancreatic stenting is associated with higher rates of PEP in high-risk patients and does not eliminate severe PEP. SN - 1097-6779 UR - https://www.unboundmedicine.com/medline/citation/25686874/Factors_associated_with_post_ERCP_pancreatitis_and_the_effect_of pancreatic_duct_stenting_in_a_pediatric_population_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0016-5107(14)02470-5 DB - PRIME DP - Unbound Medicine ER -